Peripheral Perfusion Targeted Fluid Management
1 other identifier
interventional
40
1 country
2
Brief Summary
- Impaired peripheral perfusion is related to worse outcome in critically ill patients. Although this is known, these parameters have never been used as target for hemodynamic therapy.
- We hypothesize that targeting of fluid administration on parameters of peripheral perfusion might prevent excessive fluid administration, leading to less formation of tissue edema, less respiratory dysfunction and shorter duration of mechanical ventilation in critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4 sepsis
Started Oct 2011
Typical duration for phase_4 sepsis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2011
CompletedFirst Posted
Study publicly available on registry
July 19, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedJanuary 6, 2014
January 1, 2014
2.3 years
July 7, 2011
January 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fluid balance during Intensive Care Unit stay
Total and daily fuid balance for a maximal time period of 72 hours
untill 72 hours after admission
Secondary Outcomes (6)
CRT (Capillary refill time)
Within 72 hours after admission
Systemic hemodynamic variables
Untill 72 hours after admission to the ICU
Respiratory function
Untill 72 hours after admission to the ICU
PFI (Peripheral Flow Index)
Untill 72 hours after ICU admission
Tskindiff (Forearm-to-Fingertip temperature skin difference)
Untill 72 hours after ICU admission
- +1 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONThe fluid management algorithm of the control group is based on the standard care procedure of our ICU as recommended in guidelines: the patient's fluid status is assessed by performing a fluid challenge with a bolus of 250 ml colloids. When the patients is fluid responsive (i.e. showing an increase in stroke volume \> 10% ) he will receive an additional bolus of 250 ml of colloids. After each fluid challenge, patients will be revaluated for fluid responsiveness to access need of further fluid administration.
PPTFM
EXPERIMENTALThe fluid management algorithm of the intervention group uses identical therapy (i.e. fluids) yet targeted at different endpoints (i.e. peripheral perfusion parameters). After evaluation of peripheral perfusion, only patients with a "bad peripheral perfusion" (i.e. 3 out of 4 criteria considered as bad) will receive a fluid challenge, the same way as in the standard care procedure (i.e. bolus of 250 ml of fluid). After each fluid challenge, patients will be re-evaluated for peripheral perfusion to access further need in fluid challenges. To ensure that no hypovolemia will occur in the intervention group, fluid will be administered irrespectively of peripheral perfusion parameters, if cardiac index falls below a value of 2,5 L/min/m2.
Interventions
Peripheral Perfusion Targeted Fluid Management
Eligibility Criteria
You may qualify if:
- All adult patients (\>18 years) admitted to the intensive care with 1) hemodynamic instability due to severe sepsis, and 2) a mean arterial pressure \< 65 mmHg and 3) an arterial lactate concentration \> 3.0 mmol/L will be considered for participation
You may not qualify if:
- moribund.
- severe coagulation disorder (contraindication for central venous catheter placement).
- severe peripheral vascular disease (interfering with peripheral perfusion measurement).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
ErasmusMC
Rotterdam, South Holland, 3015 CE Rotterdam, Netherlands
ErasmusMC
Rotterdam, South Holland, 3015 CE Rotterdam, Netherlands
Related Publications (3)
Lima A, Jansen TC, van Bommel J, Ince C, Bakker J. The prognostic value of the subjective assessment of peripheral perfusion in critically ill patients. Crit Care Med. 2009 Mar;37(3):934-8. doi: 10.1097/CCM.0b013e31819869db.
PMID: 19237899BACKGROUNDLima A, van Bommel J, Sikorska K, van Genderen M, Klijn E, Lesaffre E, Ince C, Bakker J. The relation of near-infrared spectroscopy with changes in peripheral circulation in critically ill patients. Crit Care Med. 2011 Jul;39(7):1649-54. doi: 10.1097/CCM.0b013e3182186675.
PMID: 21685739BACKGROUNDvan Genderen ME, Engels N, van der Valk RJ, Lima A, Klijn E, Bakker J, van Bommel J. Early peripheral perfusion-guided fluid therapy in patients with septic shock. Am J Respir Crit Care Med. 2015 Feb 15;191(4):477-80. doi: 10.1164/rccm.201408-1575LE. No abstract available.
PMID: 25679107DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jasper van Bommel, MD, PhD
Erasmus Medical Center
- PRINCIPAL INVESTIGATOR
Michel E Genderen, Drs
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Drs
Study Record Dates
First Submitted
July 7, 2011
First Posted
July 19, 2011
Study Start
October 1, 2011
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
January 6, 2014
Record last verified: 2014-01